May 26, 2017 11:29 AM EDT

Kite catches the inside track on the last leg of a race to the finish line with Novartis on a CAR-T first

The race between Novartis $NVS and Kite $KITE to win the first FDA approval of a CAR-T for cancer is now in the final stretch …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Kite catch­es the in­side track on the last leg of a race to the fin­ish line with No­var­tis on a CAR-T first